Synthesis, Characterization, Antibacterial, Antioxidant Studies of New 2-(5-(2-((1E,2E)-3- (2-methoxyphenyl)allylidene)hydrazinyl)-1,3,4- oxadiazol-2-yl)Phenol with the Some Transition Metalions

Authors

  • Fayez Awaid Namah Chemistry Department, College of Science, University of Thi-Qar, Iraq Author
  • Ibrahim A. Flifel Chemistry Department, College of Science, University of Thi-Qar, Iraq. Author
  • Saher A. Ali Chemistry Department, College of Science, University of Thi-Qar, Iraq. Author

DOI:

https://doi.org/10.61841/3z7pmp12

Keywords:

Ligand, Complexes, Characterization, Electrostatic Potential, Antibacterial

Abstract

A new ligand,, 2-(5-(2-((1E,2E) -3-(2-methoxyphenyl)allylidene)hydrazinyl) -1,3,4-oxadiazol-2-yl)phenol and its complexes with Cr(ІІІ), Co(ІІ), Ni(ІІ), and Cu(ІІ) ions were synthesized. The new ligand and its complexes have been characterized on the basis of their spectra of H1NMR, mass, Fourier transform infrared (FTIR), as well as magnetic susceptibility, elemental analysis (CHN), and conductance measurements. The program of HyperChem 8 has been used for theoretical accounts using the PM3 method to study the electrostatic potential that provided good information about the complexity site. Of the result obtained, we can suggest octahedral geometries for Cr(ІІІ), tetrahedral geometry for Co(ІІІ), and square planar geometry for Ni(ІІ) and Cu(ІІ). The antioxidant activity of the ligand was evaluated by DPPH scavenging, and the ligand showed high antioxidant activity. The ligand and its complex gave good activity antibacterial. 

Downloads

Download data is not yet available.

References

[1] C. S. De Oliveira, B. F. Lira, J. M. Barbosa-Filho, J. G. F. Lorenzo and P. F. De Athayde-Fiho, "synthetic

approaches and pharmacological activity of 1,3,4-oxadiazoles: A review of the literature from 2000-2012,"

Molecules, 17(12), 10192-10231, 2012.

[2] S. M. Zachariah, M. Ramkumar, N. George, M. S. Ashif, and M. April, “Sciences A Review on

Oxadiazole,” Res. J. Pharm. Biol. Chem. Sci., vol. 6, no. 2, pp. 205–219, 2015.

[3] A. Pangal and J. A. Shaikh, "Various Pharmacological aspects of 2, 5-Disubstituted 1,3,4-Oxadiazole

Derivatives: A Review," Res. J. Chem. Sci. 3(12), 79-89, 2013.

[4] P. W. Lei, Z. Jian, and Z. H. Fang, “Potent antibacterial agents: pyridinium-functionalized amphiphiles

bearing 1, 3, 4-oxadiazole scaffolds,” Springer-Online, 2016.

[5] I.A.Flifel, A. H.Gatea, S.A.ali, “Synthesis, Characterization, Antimicrobial New 2,2'-[(1E,2E)-ethane-1,2-diylidenedi(2E)hydrazin-1-yl-2-ylidene]bis(5-methyl-1,3,4-oxadiazole) and their transition.” J. Thi-Qar sci. 6, 1991-8690, 2017.

[6] T. Zhang et al., “Antibacterial and Antifungal Activities of 2- (substituted ether) -5- ( 1- phenyl-5- ( tri fl u uoromethyl ) -1 H -pyrazol-4-yl ) -1, 3,4-oxadiazole Derivatives,” Wiley Period., pp. 4–10, 2017.

[7] V. B. Iyer, B. M. Gurupadayya, K. V. Sairam, B. Inturi, R. S. Chandan, and A. K. Tengli, “AntiInflammatory Activity of 1,3,4-Oxadiazoles Derived from Benzoxazole,” J. Pharm. Sci. Pharmacol., vol.

2, no. 3, pp. 233–241, 2015.

[8] M. Agarwal, V. Singh, S. K. Sharma, P. Sharma, Md. Y. Ansari, S. S. Jadav, S. Yasmin, R. Sreenivasulu,

M. Z. Hassan, V. Saini & M. Jawed, "Design and synthesis of new 2,5-disubstituted-1,3,4-oxadiazole

analogues as anticancer agents", Medicinal Chemistry Research, 25(10), 2289–2303, 2016.

[9] N. Siddiqui, J. Akhtar, and M. S. Yar, “Substituted phenyl containing 1,3,4-oxadiazole-2-yl-but-2-

enamides: synthesis and preliminary evaluation as promising anticonvulsants”, Med. Chem. Res., 23(11).

2014.

[10] L. Dong, B. Song, J. Wu, Z. Wu, Y. Zhu, and D. Hu, “Synthesis and antiviral activity of novel thioether

derivatives containing 1,3,4-oxadiazole/thiadiazole and emodin moieties,” Phosphorus. Sulfur. Silicon

Relat. Elem., vol. 191, no. 6, pp. 904–907, 2016.

[11] Z. Hajimahdi, A. Zarghi, R. Zabihollahi, and M. R. Aghasadeghi, “Synthesis, biological evaluation, and

molecular modeling studies of new 1,3,4-oxadiazole- and 1,3,4-thiadiazole-substituted 4-oxo-4Hpyrido[1,2-a]pyrimidines as anti-HIV-1 agents,” med. Chem. Res., 22(5), 2467-2475, 2012.

[12] R. V Shingalapur, K. M. Hosamani, R. S. Keri, and M. H. Hugar, “European Journal of Medicinal

Chemistry Derivatives of benzimidazole pharmacophore : Synthesis, anticonvulsant, antidiabetic and DNA

cleavage studies,” Eur. J. Med. Chem., vol. 45, no. 5, pp. 1753–1759, 2010.

[13] N. C. D. A. R. Trivedi and H. V. V. H. C. Somani, “Synthesis and biological evaluation of 1, 3, 4-

oxadiazole bearing dihydropyrimidines as potential antitubercular agents,” Med. Chem. Res., vol. 2, no. 25,

pp. 329–338, 2015.

[14] S. J. Gilani, S. A. Khan, and N. Siddiqui, “Bioorganic & Medicinal Chemistry Letters Synthesis and

pharmacological evaluation of condensed heterocyclic derivatives of isoniazid,” Bioorg. Med. Chem. Lett.,

vol. 20, no. 16, pp. 4762–4765, 2010.

[15] G. Chawla, B. Naaz, A. A. Siddiqui, “Exploring 1, 3, 4-Oxadiazole Scaffold For Anti-inflammatory And

Analgesic Activities: A Review Of Literature From 2005-2016,” Mini Reviews in Medicinal Chemistry,

18(3), 216-233, 2018.

[16] N. Renuka, H. K. Vivek, G. Pavithra, and K. A. Kumar, “Synthesis of Coumarin Appended Pyrazolyl-

1,3,4-Oxadiazoles and Pyrazolyl-1,3,4-Thiadiazoles: Evaluation of Their In Vitro Antimicrobial and

Antioxidant Activities and Molecular Docking Studies,” Russ. J. Bioorganic Chem., vol. 43, no. 2, pp.

197–210, 2017.

[17] M. Bouanis, M. Tourabi, A. Nyassi, A. Zarrouk, C. Jama, and F. Bentiss, “Corrosion inhibition

performance of 2,5-bis(4-dimethylaminophenyl)-1,3,4-oxadiazole for carbon steel in HCl solution:

Gravimetric, electrochemical and XPS studies,” Applied Surface Science, vol. 389. Elsevier B.V., pp. 952–

966, 2016.

[18] G. Zhou, Y. Cheng, L. Wang, X. Jing and F. Wang, Novel polyphenylenes containing phenol-substituted

oxadiazole moieties as fluorescent chemosensors for fluoride ion”, Macromolecules, 38(6), 2148-2153,

2005.

[19] K. Hunger, Industrial Dyes Chemistry, Properties, Applications. Wiley-VCH, 2003.

[20] C. Anghel, M. Matache, C. C. Paraschivescu, A. M. Madalan, and M. Andruh, “A novel 1-D coordination

polymer constructed from disilver-1,3,4-oxadiazole nodes and perchlorato bridges Catalin,” ElsevierInorganic Chem. Commun., vol. 76, pp. 22–25, 2017.

[21] N. Deshapande, N. S. Belavagi, S. I. Panchamukhi, M. Hussain, I. Ahmed, and M. Khazi, “Synthesis and

optoelectronic properties of thieno[2,3-b]thiophene based bis 1,3,4-oxadiazole derivatives as blue

fluorescent material for use in organic light emitting diodes,” ElsOPTICAL Mater., 37(2), 516–519, 2014.

[22] Dina A. Najeeb, “Some Transition Metal Complexes with 2-thioacetic acid-5-pyridyl- 1,3,4-oxadiazol,” J.

Al-Nahrain Univ., vol. 14, no. 3, pp. 35–39, 2011.

[23] K. Kishore, A. Samad, Y. Kumar, M. Shaharyar, R. L. Khosa, J. Jain, V. Kumar, Priyanka Singh,

“European Journal of Medicinal Chemistry Design, synthesis and biological evaluation of 1, 3, 4-

oxadiazole derivatives,” Eur. J. Med. Chem., vol. 45, no. 11, pp. 4963–4967, 2010.

[24] P. Derivatives, M. T. Abdel-aal, W. A. El-sayed, S. M. El-kosy, and E. S. H. El-ashry, “Synthesis and

Antiviral Evaluation of Novel 5-(N-Aryl- aminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and Their Sugars,

1,2,4-Triazoles, Tetrazoles and Pyrazolyl Derivatives,” Arch. Pharm. Chem. Life Sci, vol. 341, pp. 307–

313, 2008.

[25] M. S. Yadawe, S. N. Unki, and S. A. Patil, “Synthesis, Spectral Characterization and Biological Studies of

Lanthanum ( III ) Complexes with Schiff Bases,” Int. Lett. Chem. Phys. Astron., vol. 12, pp. 94–104, 2013.

[26] H. A. Mohamad, B. Mohamad, and H. Ameem, “Synthesis and Characterization of Co(II), Ni(II) and

Cu(II) Complexes with Thio-1,3,4-oxadiazole Derivatives,” Cryst. Ideas–The Role Chem. Springer Int.

Publ., pp. 253–266, 2016.

[27] S. Menati, H. Amiri, B. Askari, M. Riahi, F. Jalilian, and G. Dini, “Synthesis and characterization of

insoluble cobalt(II), nickel(II), zinc(II) and palladium(II) Schiff base complexes: Heterogeneous catalysts

for oxidation of sulfides with hydrogen peroxide,” Comptes rendus - Chim.,pp.1-10, 2015.

[28] N. Nazarbahjat, A. Ariffin, Z. Abdullah, M. A. Abdulla, J. K. S. Shia, K. H. Leong, "Synthesis,

characterization, drug-likeness properties and determination of the in vitro antioxidant and cytotoxic

activities of new 1,3,4-oxadiazole derivatives", Med. Chem. Res., 25(9), 2015-2029, 2016.

[29] D.. A. T. Gary.L.Miessler, “Inorganic chemistry” 2nd Ed. pearson prentice hall, Upper Saddle River, NJ,

1991.

[30] R. M. Shakir, A. Ariffin and M. A. Abdulla, "Synthesis of New 2,5-Di-substituted 1,3,4-Oxadiazoles

Bearing 2,6-Di-tert-butylphenol Moieties and Evaluation of Their Antioxidant Activity", Molecules, 19(3),

3436-3449, 2014.

[31] N. Nazarbahjat, F. A. Kadir, A. Ariffin, M. A. Abdulla, Z. Abdullah, & W. A. Yehye, "Antioxidant

Properties and Gastroprotective Effects of 2-(Ethylthio)Benzohydrazones on Ethanol-Induced Acute

Gastric Mucosal Lesions in Rats", PLOS ONE., 11(6), 1-21, 2016.

[32] I. Ahmad, and A. Z. Beg, "Antimicrobial and photochemical studies on 45 Indian medicinal plants against

multi-drug resistant human pathogens" Ethnopharmacology J., 74(2), 113-123, 2001.

[33] R. Hout,W. J. Pietro and W. J. Herhre, A pictorial Approach to Molecular Structure and Reactivity, John

Wiley, New York, 1, (1984).

Downloads

Published

31.07.2020

How to Cite

Awaid Namah, F., A. Flifel , I., & A. Ali , S. (2020). Synthesis, Characterization, Antibacterial, Antioxidant Studies of New 2-(5-(2-((1E,2E)-3- (2-methoxyphenyl)allylidene)hydrazinyl)-1,3,4- oxadiazol-2-yl)Phenol with the Some Transition Metalions. International Journal of Psychosocial Rehabilitation, 24(5), 1467-1480. https://doi.org/10.61841/3z7pmp12